title: The relationship between the prothrombin upstream sequence element and the G20210A polymorphism: the influence of a competitive environment for mRNA 3'-end formation.
abstract: The human prothrombin G20210A polymorphism located at the 3' cleavage site of the mRNA results in elevated plasma prothrombin levels and increased risk of venous thrombosis. This polymorphism has been shown to directly influence a variety of processes related to prothrombin mRNA metabolism. We have constructed plasmids that express the full-length prothrombin mRNA that is polyadenylated at its natural site. The A allele prothrombin variant was more efficient than the G allele at promoting cleavage at this site in the presence of a competing poly (A) sequence. In the absence of competition, both allelic variants give rise to a similar level of cleavage site heterogeneity. An upstream sequence element (USE) was also identified within the prothrombin 3'-UTR. When placed upstream of two competing poly (A) sites, the USE directed cleavage preferentially to the proximal poly (A) site. In the absence of competition, the USE had no effect on cleavage site selection. This study suggests that the basis for the increase in prothrombin expression in A allele carriers is not due to allelic changes in cleavage site selection per se. In addition, the functionality of USEs needs to be considered within the context of endogenous sequence architecture.
authors.affiliation: Monash University, Department of Medicine, Australian Centre for Blood Diseases 6th Floor, Burnet Building, AMREP, Commercial Road Prahran, Victoria 3181, Australia.
authors.forename: Mythily
authors.initials: M
authors.lastname: Sachchithananthan
authors.forename: Stan J
authors.initials: SJ
authors.lastname: Stasinopoulos
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Wilusz
authors.forename: Robert L
authors.initials: RL
authors.lastname: Medcalf
mesh_terms: D020413:3' Untranslated Regions; D001483:Base Sequence; D017124:Conserved Sequence; D006801:Humans; D008969:Molecular Sequence Data; D026723:Polyadenylation; D020641:Polymorphism, Single Nucleotide; D011516:Prothrombin / Q000096:biosynthesis / Q000235:genetics*; D026721:RNA 3' End Processing; D012333:RNA, Messenger / Q000737:chemistry / Q000378:metabolism*; D038621:Regulatory Sequences, Ribonucleic Acid
chemical_list: D020413:3' Untranslated Regions; D012333:RNA, Messenger; D038621:Regulatory Sequences, Ribonucleic Acid; D011516:Prothrombin
references.citation: Genome Res. 2000 Jul;10(7):1001-10
references.pmid: 10899149
references.citation: Mol Cell Biol. 1999 Jul;19(7):4971-9
references.pmid: 10373547
references.citation: Mol Cell Biol. 2000 Apr;20(8):2660-9
references.pmid: 10733568
references.citation: Blood. 2000 May 1;95(9):2780-5
references.pmid: 10779421
references.citation: Nat Genet. 2001 Aug;28(4):389-92
references.pmid: 11443298
references.citation: Genome Res. 2001 Sep;11(9):1520-6
references.pmid: 11544195
references.citation: Mol Cell Endocrinol. 2002 Apr 25;190(1-2):1-8
references.pmid: 11997173
references.citation: Thromb Haemost. 2002 May;87(5):846-53
references.pmid: 12038788
references.citation: Mol Cell Biol. 2002 Jul;22(13):4579-86
references.pmid: 12052867
references.citation: Blood. 2002 Jul 1;100(1):359-62
references.pmid: 12070052
references.citation: J Biol Chem. 2002 Sep 27;277(39):35808-14
references.pmid: 12082089
references.citation: J Biol Chem. 2002 Nov 8;277(45):42733-40
references.pmid: 12200454
references.citation: Nucleic Acids Res. 2003 Mar 1;31(5):1375-86
references.pmid: 12595544
references.citation: BMC Genomics. 2003 Feb 25;4(1):7
references.pmid: 12600277
references.citation: Bioessays. 2003 Dec;25(12):1220-8
references.pmid: 14635257
references.citation: Blood. 2004 Jan 15;103(2):586-93
references.pmid: 14504098
references.citation: J Thromb Haemost. 2004 Jan;2(1):119-27
references.pmid: 14717975
references.citation: Blood. 2004 Jul 15;104(2):428-35
references.pmid: 15059842
references.citation: Anal Biochem. 1987 Apr;162(1):156-9
references.pmid: 2440339
references.citation: Gene. 1989 Apr 15;77(1):51-9
references.pmid: 2744487
references.citation: Mol Cell Biol. 1989 Nov;9(11):4951-61
references.pmid: 2601703
references.citation: Genes Dev. 1990 May;4(5):764-76
references.pmid: 2379828
references.citation: Nucleic Acids Res. 1990 Oct 11;18(19):5799-805
references.pmid: 2170946
references.citation: Genes Dev. 1990 Sep;4(9):1552-9
references.pmid: 1701407
references.citation: Genes Dev. 1991 Jul;5(7):1277-84
references.pmid: 1712333
references.citation: Mol Cell Biol. 1992 Dec;12(12):5386-93
references.pmid: 1333042
references.citation: Nucleic Acids Res. 1994 Jul 11;22(13):2525-31
references.pmid: 7518915
references.citation: Genes Dev. 1995 Jan 1;9(1):72-83
references.pmid: 7828853
references.citation: Nucleic Acids Res. 1995 Jul 25;23(14):2614-20
references.pmid: 7651822
references.citation: Blood. 1996 Nov 15;88(10):3698-703
references.pmid: 8916933
references.citation: Nucleic Acids Res. 1997 Jun 15;25(12):2326-36
references.pmid: 9171082
references.citation: Br J Haematol. 1997 Sep;98(4):907-9
references.pmid: 9326187
references.citation: Thromb Haemost. 1997 Dec;78(6):1426-9
references.pmid: 9423788
references.citation: Ann Intern Med. 1998 Jul 15;129(2):89-93
references.pmid: 9669991
references.citation: Genes Dev. 1998 Aug 15;12(16):2522-34
references.pmid: 9716405
references.citation: Thromb Haemost. 1998 Sep;80(3):366-9
references.pmid: 9759610
references.citation: Eur J Biochem. 1998 Nov 15;258(1):123-31
references.pmid: 9851700
references.citation: Gene. 1999 Apr 29;231(1-2):77-86
references.pmid: 10231571
references.citation: Mol Cell Biol. 1999 Jun;19(6):4311-23
references.pmid: 10330172
references.citation: Microbiol Mol Biol Rev. 1999 Jun;63(2):405-45
references.pmid: 10357856
references.citation: FEMS Microbiol Rev. 1999 Jun;23(3):277-95
references.pmid: 10371034
references.citation: Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14055-60
references.pmid: 10570197